Hepatocellular Ballooning is Due to Highly Pronounced Glycogenosis Potentially Associated with Steatosis and Metabolic Reprogramming.

Carbohydrate metabolism Chronic liver disease Insulin signaling Metabolic reprogramming Preneoplasia

Journal

Journal of clinical and translational hepatology
ISSN: 2310-8819
Titre abrégé: J Clin Transl Hepatol
Pays: United States
ID NLM: 101649815

Informations de publication

Date de publication:
28 Jan 2024
Historique:
received: 18 05 2023
revised: 22 08 2023
accepted: 05 09 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: ppublish

Résumé

Hepatocellular ballooning is a common finding in chronic liver disease, mainly characterized by rarefied cytoplasm that often contains Mallory-Denk bodies (MDB). Ballooning has mostly been attributed to degeneration but its striking resemblance to glycogenotic/steatotic changes characterizing preneoplastic hepatocellular lesions in animal models and chronic human liver diseases prompts the question whether ballooned hepatocytes (BH) are damaged cells on the path to death or rather viable cells, possibly involved in neoplastic development. Using specimens from 96 cirrhotic human livers, BH characteristics were assessed for their glycogen/lipid stores, enzyme activities, and proto-oncogenic signaling cascades by enzyme- and immunohistochemical approaches with serial paraffin and cryostat sections. BH were present in 43.8% of cirrhotic livers. Particularly pronounced excess glycogen storage of (glycogenosis) and/or lipids (steatosis) were characteristic, ground glass features and MDB were often observed. Decreased glucose-6-phosphatase, increased glucose-6-phosphate dehydrogenase activity and altered immunoreactivity of enzymes involved in glycolysis, lipid metabolism, and cholesterol biosynthesis were discovered. Furthermore, components of the insulin signaling cascade were upregulated along with insulin dependent glucose transporter glucose transporter 4 and the v-akt murine thymoma viral oncogene homolog/mammalian target of rapamycin signaling pathway associated with BH are hallmarked by particularly pronounced glycogenosis with facultative steatosis, many of their features being reminiscent of metabolic aberrations documented in preneoplastic hepatocellular lesions in experimental animals and chronic human liver diseases. Hence, BH are not damaged entities facing death but rather viable cells featuring metabolic reprogramming, indicative of a preneoplastic nature.

Sections du résumé

Background and Aims UNASSIGNED
Hepatocellular ballooning is a common finding in chronic liver disease, mainly characterized by rarefied cytoplasm that often contains Mallory-Denk bodies (MDB). Ballooning has mostly been attributed to degeneration but its striking resemblance to glycogenotic/steatotic changes characterizing preneoplastic hepatocellular lesions in animal models and chronic human liver diseases prompts the question whether ballooned hepatocytes (BH) are damaged cells on the path to death or rather viable cells, possibly involved in neoplastic development.
Methods UNASSIGNED
Using specimens from 96 cirrhotic human livers, BH characteristics were assessed for their glycogen/lipid stores, enzyme activities, and proto-oncogenic signaling cascades by enzyme- and immunohistochemical approaches with serial paraffin and cryostat sections.
Results UNASSIGNED
BH were present in 43.8% of cirrhotic livers. Particularly pronounced excess glycogen storage of (glycogenosis) and/or lipids (steatosis) were characteristic, ground glass features and MDB were often observed. Decreased glucose-6-phosphatase, increased glucose-6-phosphate dehydrogenase activity and altered immunoreactivity of enzymes involved in glycolysis, lipid metabolism, and cholesterol biosynthesis were discovered. Furthermore, components of the insulin signaling cascade were upregulated along with insulin dependent glucose transporter glucose transporter 4 and the v-akt murine thymoma viral oncogene homolog/mammalian target of rapamycin signaling pathway associated with
Conclusions UNASSIGNED
BH are hallmarked by particularly pronounced glycogenosis with facultative steatosis, many of their features being reminiscent of metabolic aberrations documented in preneoplastic hepatocellular lesions in experimental animals and chronic human liver diseases. Hence, BH are not damaged entities facing death but rather viable cells featuring metabolic reprogramming, indicative of a preneoplastic nature.

Identifiants

pubmed: 38250461
doi: 10.14218/JCTH.2023.00242
pii: JCTH.2023.00242
pmc: PMC10794273
doi:

Types de publication

Journal Article

Langues

eng

Pagination

52-61

Informations de copyright

© 2024 Authors.

Déclaration de conflit d'intérêts

The authors have no conflict of interests related to this publication.

Auteurs

Silvia Ribback (S)

Institut für Pathologie, Universitaetsmedizin Greifswald, Greifswald, Germany.

Kristin Peters (K)

Institut für Pathologie, Universitaetsmedizin Greifswald, Greifswald, Germany.

Mohd Yasser (M)

Institut für Pathologie, Universitaetsmedizin Greifswald, Greifswald, Germany.

Jessica Prey (J)

Institut für Pathologie, Universitaetsmedizin Greifswald, Greifswald, Germany.

Paula Wilhelmi (P)

Institut für Pathologie, Universitaetsmedizin Greifswald, Greifswald, Germany.

Qin Su (Q)

Cell Marque, Millipore-Sigma, Rocklin, CA, USA.

Frank Dombrowski (F)

Institut für Pathologie, Universitaetsmedizin Greifswald, Greifswald, Germany.

Peter Bannasch (P)

German Cancer Research Center (DKFZ), Heidelberg, Germany.

Classifications MeSH